BRISTOL-MYERS SQUIBB COMPANY for BRISTOL-MYERS SQUIBB COMPANY
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R.1492, Ensuring Pathways to Innovation Cures (EPIC) Act Implementation of Inflation Reduction Act of 2022 ORPHAN Cures Act MINI Act Discussions regarding H.R.1, One Big Beautiful Bill Act regarding bio-pharmaceutical provisions Biosimilars reimbursement issues H.R.4299, the Protecting Patient Access to Cancer and Complex Therapies Act of 2025 H.R.1968, lobbied for passage of the Continuing Resolution to include PBM reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BRUNET | — |
| RODGER CURRIE | — |
| SOFIA FOX | — |
| KIRBY MILLER | — |
| LANE PENRY | — |
Medicare/Medicaid MMM
Issues related to the 340B Drug Pricing Program - regarding all bio-pharmaceutical related provisions H.R.7635, the 340B PATIENTS Act Issues related to the six protected classes of medicines under Medicare Part D, regarding all bio-pharmaceutical issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| RODGER CURRIE | — |
| SOFIA FOX | — |
| KIRBY MILLER | — |
| KATHRYN NOVARIA | — |
| LANE PENRY | — |
Taxation/Internal Revenue Code TAX
Proposed policies regarding corporate tax reform - regarding all bio-pharmaceutical related provisions Discussions regarding OECD implementation
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEOUDES | — |
| LANE PENRY | — |
Copyright/Patent/Trademark CPT
Intellectual Property Reform concerning bio-pharmaceutical industry
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BRUNET | — |
| RODGER CURRIE | — |
| SOFIA FOX | — |
| KIRBY MILLER | — |
| LANE PENRY | — |
Pharmacy PHA
S.864, HELP Copays Act S.526, Pharmacy Benefit Manager Transparency Act of 2025 H.R.3285, Fairness for Patient Medications Act S.1339, Pharmacy Benefit Manager Reform Act Modernizing and Ensuring Equity Act H.R.3521, Clinical Trials Modernization Act Discussions regarding Continuing Resolution to include PBM reform, H.R.1968
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BRUNET | — |
| SOFIA FOX | — |
| KIRBY MILLER | — |
Trade (domestic/foreign) TRD
International Reference Pricing/Most Favored Nation, including all bio-pharmaceutical issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| RODGER CURRIE | — |
| JOHN DEOUDES | — |
| SOFIA FOX | — |
| KIRBY MILLER | — |
| KATHRYN NOVARIA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.